Effect of megestrol acetate (Megace®) on steroid metabolism and steroid-protein binding in the human prostate

Journal of Clinical Endocrinology and Metabolism

Volumn 43, Issue 5, 1976, Pages 1000-1008

  Geller, Jack ^a,b   Albert, Jerry ^a,b   Geller, Suzanne ^a,b   Lopez, Debra ^a,b   Cantor, Thomas ^a,b   Yen, Samuel ^a,b  

^a SCRIPPS MERCY HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; ANDROSTANEDIOL; ANDROSTANOLONE; ANDROSTANOLONE H 3; ANDROSTENEDIONE C 14; CYPROTERONE ACETATE; FLUOXYMESTERONE; MEGESTROL ACETATE; OXIDOREDUCTASE; POLYESTRADIOL; POLYESTRADIOL PHOSPHATE; RADIOISOTOPE; STEROID HORMONE; TESTOSTERONE H 3; UNCLASSIFIED DRUG;

ARTICLE; CYTOSOL; MAJOR CLINICAL STUDY; PROSTATE; PROSTATE HYPERTROPHY;

DIHYDROTESTOSTERONE; FLUOXYMESTERONE; FOLLICLE STIMULATING HORMONE; HUMANS; LUTEINIZING HORMONE; MALE; MEGESTROL; PROLACTIN; PROSTATE; PROSTATIC HYPERPLASIA; RECEPTORS, ANDROGEN; RECEPTORS, STEROID; TESTOSTERONE; TESTOSTERONE 5-ALPHA-REDUCTASE;

EID: 0017095652     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jcem-43-5-1000     Document Type: Article

References (17)

1. Siiteri, P. K., and J. D. Wilson, Dihydrotestosterone in prostatic hypertrophy: I. The formation and content of dihydrotestosterone in the hypertrophic prostate of man, J Clin Invest 49: 1737, 1970.
2. Geller, J., J. Albert, D. Lopez, and S. Geller, Comparison of endogenous androgen metabolites in normal human prostate and benign prostatic hypertrophy (BPH), The Endocrine Society Program, 57th Annual Meeting, June, 1975, (Abstract 371).
3. Grayhack, J. T., Pituitary factors influencing growth of the prostate, Nat Cancer Inst Monogr 12: 189, 1963.
4. Geller, J., T. Cantor, and J. Albert, Evidence for a specific dihydrotestosterone-binding cytosol receptor in the human prostate, J Clin Endocrinol Metab 41: 854, 1975.
5. Albert, J., J. Geller, S. Geller, and D. Lopez, Prostate concentrations of endogenous androgens by radioimmunoassay, J Steroid Biochem 7: 301, 1976.
6. Yen, S. S. C., O. Llerena, B. Little, and O. H. Pearson, Disappearance rates of endogenous luteinizing hormone and chorionic gonadotropin in man, J Clin Endocrinol Metab 28: 1763, 1968.
7. Yen, S. S. C., L. A. Llerena, O. H. Pearson, and A. S. Littell, Disappearance rates of endogenous follicle-stimulating hormone in serum following surgical hypophysectomy in man, J Clin Endocrinol Metab 30: 325, 1970.
8. Sinha, Y. N., F. W. Selby, U. J. Lewis, and W. P. VanderLaan, A homologous radioimmunoassay for human prolactin, J Clin Endocrinol Metab 36: 509, 1973.
9. Ehara, Y., T. M. Siler, G. VandenBerg, Y. N. Sinha, and S. S. C. Yen, Circulating prolactin levels during the menstrual cycle: Episodic release and diurnal variation, Am J Obstet Gynecol 117: 962, 1973.
10. Mainwaring, W. I. P., and E. J. G. Milroy, Characterization of the specific androgen receptors in the human prostate gland, J Endocrinol 57: 371, 1973.
11. Tan, S. Y., I. Antonipillai, and B. E. Pearson Murphy, Inhibition of testosterone metabolism in the human prostate, J Clin Endocrinol Metab 39: 936, 1974.
12. Orestano, F., K. Klose, A. Rubin, P. Knapstein, and J. E. Altwein, Testosterone metabolism in benign prostatic hypertrophy, Invest Urol 12: 151, 1974.
13. Moore, R. J., and J. D. Wilson, The effect of androgenic hormones on the reduced nicotinamide adenine dinucleotide phosphate: A4-3-ketosteroid 5a-oxidoreductase of rat ventral prostate, Endocrinology 93: 581, 1973.
14. Yen, S. S. C., Y. Ehara, and T. M. Siler, Augmentation of prolactin secretion by estrogen in hypogonadal women, J Clin Invest 53: 652, 1974.
15. Walsh, P. C., J. D. Madden, M. J. Harrod, J. L. Goldstein, P. C. MacDonald, and J. D. Wilson, Familial incomplete male pseudohermaphroditism, Type 2: Decreased dihydrotestosterone formation in psuedovaginal perineoscrotal hypospadias, N Engl J Med 291: 944, 1974.
16. Imperato-McGinley, J., L. Guerrero, T. Gautier, and R. Peterson, An unusual inherited form of male pseudohermaphroditism: A model of 5a-reductase deficiency in man, J Clin Invest 53: 35a, 1974 (Abstract 132).
17. Keenan, B. S., W. J. Meyer III, A. J. Hadjian, H. W. Jones, and C. J. Migeon, Syndrome of androgen insensitivity in man: Absence of 5a-dihydro- testosterone binding protein in skin fibroblasts, J Clin Endocrinol Metab 38: 1143, 1974.